Scholars@Duke

Phase 2 PVSRIPO and the Checkpoint Inhibitor Pembrolizumab in Recurrent Glioblastoma

Clinical Trial Grant
Duke Scholars
Daniel Bryce Landi
Principal Investigator Daniel Bryce Landi Pediatrics, Hematology-Oncology

Awarded By

Istari Oncology

Start Date

January 8, 2021

End Date

July 23, 2024
 

Awarded By

Istari Oncology

Start Date

January 8, 2021

End Date

July 23, 2024